Impact of adalimumab on clinical outcomes, healthcare resource utilization, and sick leave in patients with ankylosing spondylitis: an observational study from five Central and Eastern European countries

Impact of adalimumab on clinical outcomes, healthcare resource utilization, and sick leave in patients with ankylosing spondylitis: an observational study from five Central and Eastern European countries

Background: Patients with ankylosing spondylitis (AS) are substantial users of healthcare resources due to chronic and potentially disabling disease. This study assessed the impact of adalimumab on clinical outcomes, healthcare resource utilization, and sick leave in patients with AS in five Cen...

Full description

Bibliographic Details
Main Authors: Daniela Opris-Belinski, Shandor F Erdes, Simeon Grazio, Ladislav Šenolt, Maja Hojnik, Orsolya Nagy, Diana Marina, Sándor Szántó
Format: Article
Language:English
Published: BioExcel Publishing Ltd 2018-11-01
Series:Drugs in Context
Subjects:
adalimumab
ankylosing spondylitis
disease activity
healthcare resource utilization
physical function
work outcomes.
Online Access:https://www.drugsincontext.com/impact-of-adalimumab-on-clinical-outcomes-healthcare-resource-utilization-and-sick-leave-in-patients-with-ankylosing-spondylitis-an-observational-study-from-five-central-and-eastern-european-countries

Internet

https://www.drugsincontext.com/impact-of-adalimumab-on-clinical-outcomes-healthcare-resource-utilization-and-sick-leave-in-patients-with-ankylosing-spondylitis-an-observational-study-from-five-central-and-eastern-european-countries

Similar Items